Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
Purpose To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. Methods A total of 56 plans were generated...
Gespeichert in:
| Veröffentlicht in: | Journal of applied clinical medical physics 2020-07, Vol.21 (7), p.39-48 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 48 |
|---|---|
| container_issue | 7 |
| container_start_page | 39 |
| container_title | Journal of applied clinical medical physics |
| container_volume | 21 |
| creator | Laugeman, Eric Heermann, Ana Hilliard, Jessica Watts, Michael Roberson, Marshia Morris, Robert Goddu, Sreekrishna Sethi, Abhishek Zoberi, Imran Kim, Hyun Mutic, Sasa Hugo, Geoffrey Cai, Bin |
| description | Purpose
To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors.
Methods
A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218.
Results
TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans.
Conclusion
Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented. |
| doi_str_mv | 10.1002/acm2.12881 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2398619378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2398619378</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4481-68b0b973a4b6cc71b3546e9e71b952c6c47f1a712d2beb84fc7009fe47b02a2b3</originalsourceid><addsrcrecordid>eNp9kUuLFDEURoMozsuNP0ACboaBbvPqSmojNI2PgRERnHVIUresDKlKmVT10OCPn7Q9NqMLV_lCDod78yH0mpIlJYS9M65nS8qUos_QKV2xalHXVDx_kk_QWc53hFCquHqJTjjjlVIVO0W_NrEfE3QwZL8FvDXBN2byccCxxZ0JblciWxI8BjNkbIYGTx1g348BehimIzuWVO44j-B86x3-tsb3fupwP4fJFxo3MIGbYtqrpjamPl-gF60JGV49nufo9uOH75vPi5uvn64365uFE0LRRaUssbXkRtjKOUktX4kKaiipXjFXOSFbaiRlDbNglWidJKRuQUhLmGGWn6P3B-842x4aV-ZMJugx-d6knY7G679fBt_pH3GrJVcVVaQILh8FKf6cIU-699lBKH8Ccc6a8bqANZeqoG__Qe_inIaynmaCyRUVgspCXR0ol2LOCdrjMJTofal6X6r-XWqB3zwd_4j-abEA9ADc-wC7_6j0evOFHaQP1BauOQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2427514417</pqid></control><display><type>article</type><title>Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms</title><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Laugeman, Eric ; Heermann, Ana ; Hilliard, Jessica ; Watts, Michael ; Roberson, Marshia ; Morris, Robert ; Goddu, Sreekrishna ; Sethi, Abhishek ; Zoberi, Imran ; Kim, Hyun ; Mutic, Sasa ; Hugo, Geoffrey ; Cai, Bin</creator><creatorcontrib>Laugeman, Eric ; Heermann, Ana ; Hilliard, Jessica ; Watts, Michael ; Roberson, Marshia ; Morris, Robert ; Goddu, Sreekrishna ; Sethi, Abhishek ; Zoberi, Imran ; Kim, Hyun ; Mutic, Sasa ; Hugo, Geoffrey ; Cai, Bin</creatorcontrib><description>Purpose
To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors.
Methods
A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218.
Results
TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans.
Conclusion
Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented.</description><identifier>ISSN: 1526-9914</identifier><identifier>EISSN: 1526-9914</identifier><identifier>DOI: 10.1002/acm2.12881</identifier><identifier>PMID: 32368862</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Algorithms ; Clinics ; Dosimetry ; double‐stack MLC ; patient‐specific QA ; Planning ; Process controls ; Quality control ; Radiation Oncology Physics ; Radiation therapy ; ring gantry LINAC</subject><ispartof>Journal of applied clinical medical physics, 2020-07, Vol.21 (7), p.39-48</ispartof><rights>2020 The Authors. published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.</rights><rights>2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.</rights><rights>2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4481-68b0b973a4b6cc71b3546e9e71b952c6c47f1a712d2beb84fc7009fe47b02a2b3</citedby><cites>FETCH-LOGICAL-c4481-68b0b973a4b6cc71b3546e9e71b952c6c47f1a712d2beb84fc7009fe47b02a2b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386180/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386180/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32368862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laugeman, Eric</creatorcontrib><creatorcontrib>Heermann, Ana</creatorcontrib><creatorcontrib>Hilliard, Jessica</creatorcontrib><creatorcontrib>Watts, Michael</creatorcontrib><creatorcontrib>Roberson, Marshia</creatorcontrib><creatorcontrib>Morris, Robert</creatorcontrib><creatorcontrib>Goddu, Sreekrishna</creatorcontrib><creatorcontrib>Sethi, Abhishek</creatorcontrib><creatorcontrib>Zoberi, Imran</creatorcontrib><creatorcontrib>Kim, Hyun</creatorcontrib><creatorcontrib>Mutic, Sasa</creatorcontrib><creatorcontrib>Hugo, Geoffrey</creatorcontrib><creatorcontrib>Cai, Bin</creatorcontrib><title>Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms</title><title>Journal of applied clinical medical physics</title><addtitle>J Appl Clin Med Phys</addtitle><description>Purpose
To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors.
Methods
A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218.
Results
TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans.
Conclusion
Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented.</description><subject>Algorithms</subject><subject>Clinics</subject><subject>Dosimetry</subject><subject>double‐stack MLC</subject><subject>patient‐specific QA</subject><subject>Planning</subject><subject>Process controls</subject><subject>Quality control</subject><subject>Radiation Oncology Physics</subject><subject>Radiation therapy</subject><subject>ring gantry LINAC</subject><issn>1526-9914</issn><issn>1526-9914</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kUuLFDEURoMozsuNP0ACboaBbvPqSmojNI2PgRERnHVIUresDKlKmVT10OCPn7Q9NqMLV_lCDod78yH0mpIlJYS9M65nS8qUos_QKV2xalHXVDx_kk_QWc53hFCquHqJTjjjlVIVO0W_NrEfE3QwZL8FvDXBN2byccCxxZ0JblciWxI8BjNkbIYGTx1g348BehimIzuWVO44j-B86x3-tsb3fupwP4fJFxo3MIGbYtqrpjamPl-gF60JGV49nufo9uOH75vPi5uvn64365uFE0LRRaUssbXkRtjKOUktX4kKaiipXjFXOSFbaiRlDbNglWidJKRuQUhLmGGWn6P3B-842x4aV-ZMJugx-d6knY7G679fBt_pH3GrJVcVVaQILh8FKf6cIU-699lBKH8Ccc6a8bqANZeqoG__Qe_inIaynmaCyRUVgspCXR0ol2LOCdrjMJTofal6X6r-XWqB3zwd_4j-abEA9ADc-wC7_6j0evOFHaQP1BauOQ</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Laugeman, Eric</creator><creator>Heermann, Ana</creator><creator>Hilliard, Jessica</creator><creator>Watts, Michael</creator><creator>Roberson, Marshia</creator><creator>Morris, Robert</creator><creator>Goddu, Sreekrishna</creator><creator>Sethi, Abhishek</creator><creator>Zoberi, Imran</creator><creator>Kim, Hyun</creator><creator>Mutic, Sasa</creator><creator>Hugo, Geoffrey</creator><creator>Cai, Bin</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202007</creationdate><title>Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms</title><author>Laugeman, Eric ; Heermann, Ana ; Hilliard, Jessica ; Watts, Michael ; Roberson, Marshia ; Morris, Robert ; Goddu, Sreekrishna ; Sethi, Abhishek ; Zoberi, Imran ; Kim, Hyun ; Mutic, Sasa ; Hugo, Geoffrey ; Cai, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4481-68b0b973a4b6cc71b3546e9e71b952c6c47f1a712d2beb84fc7009fe47b02a2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Algorithms</topic><topic>Clinics</topic><topic>Dosimetry</topic><topic>double‐stack MLC</topic><topic>patient‐specific QA</topic><topic>Planning</topic><topic>Process controls</topic><topic>Quality control</topic><topic>Radiation Oncology Physics</topic><topic>Radiation therapy</topic><topic>ring gantry LINAC</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laugeman, Eric</creatorcontrib><creatorcontrib>Heermann, Ana</creatorcontrib><creatorcontrib>Hilliard, Jessica</creatorcontrib><creatorcontrib>Watts, Michael</creatorcontrib><creatorcontrib>Roberson, Marshia</creatorcontrib><creatorcontrib>Morris, Robert</creatorcontrib><creatorcontrib>Goddu, Sreekrishna</creatorcontrib><creatorcontrib>Sethi, Abhishek</creatorcontrib><creatorcontrib>Zoberi, Imran</creatorcontrib><creatorcontrib>Kim, Hyun</creatorcontrib><creatorcontrib>Mutic, Sasa</creatorcontrib><creatorcontrib>Hugo, Geoffrey</creatorcontrib><creatorcontrib>Cai, Bin</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of applied clinical medical physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laugeman, Eric</au><au>Heermann, Ana</au><au>Hilliard, Jessica</au><au>Watts, Michael</au><au>Roberson, Marshia</au><au>Morris, Robert</au><au>Goddu, Sreekrishna</au><au>Sethi, Abhishek</au><au>Zoberi, Imran</au><au>Kim, Hyun</au><au>Mutic, Sasa</au><au>Hugo, Geoffrey</au><au>Cai, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms</atitle><jtitle>Journal of applied clinical medical physics</jtitle><addtitle>J Appl Clin Med Phys</addtitle><date>2020-07</date><risdate>2020</risdate><volume>21</volume><issue>7</issue><spage>39</spage><epage>48</epage><pages>39-48</pages><issn>1526-9914</issn><eissn>1526-9914</eissn><abstract>Purpose
To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors.
Methods
A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218.
Results
TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans.
Conclusion
Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>32368862</pmid><doi>10.1002/acm2.12881</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1526-9914 |
| ispartof | Journal of applied clinical medical physics, 2020-07, Vol.21 (7), p.39-48 |
| issn | 1526-9914 1526-9914 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2398619378 |
| source | DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Algorithms Clinics Dosimetry double‐stack MLC patient‐specific QA Planning Process controls Quality control Radiation Oncology Physics Radiation therapy ring gantry LINAC |
| title | Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A55%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comprehensive%20validation%20of%20halcyon%202.0%20plans%20and%20the%20implementation%20of%20patient%20specific%20QA%20with%20multiple%20detector%20platforms&rft.jtitle=Journal%20of%20applied%20clinical%20medical%20physics&rft.au=Laugeman,%20Eric&rft.date=2020-07&rft.volume=21&rft.issue=7&rft.spage=39&rft.epage=48&rft.pages=39-48&rft.issn=1526-9914&rft.eissn=1526-9914&rft_id=info:doi/10.1002/acm2.12881&rft_dat=%3Cproquest_pubme%3E2398619378%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2427514417&rft_id=info:pmid/32368862&rfr_iscdi=true |